Baku 16° C
BioNTech, Pfizer studying new COVID variant
Health
- 26 November, 2021
- 13:30
Add Report.az to preferred Google sources
Stay up to date with the top news!
BioNTech and Pfizer said that experts are studying a new variant of coronavirus discovered in South Africa, more information is expected in two weeks, Report informs.
“We expect more laboratory data in two weeks at the latest,” BioNTech spokesman said, according to Agence France-Presse.
The company stressed that the data will help to understand whether the variant of coronavirus B.1.1.529 could “require a vaccine adjustment” by Pfizer/BioNTech in the event that it spreads worldwide.
Author
Latest News
13:04
Azerbaijan's national payment system turnover rises 46%
Finance
13:02
Kamran Aliyev awards Saudi Arabia's anti-corruption chief
Foreign policy
12:58
SOCAR Department's non-oil export revenues reach $251M in nine months
Energy
12:57
Georgia plans to sign phytosanitary control agreements with Azerbaijan and other countries
Region
12:54
Photo
Azerbaijan beats Mozambique at FIFA U-15 World Cup
Football
12:53
CBA expects Mastercard and Visa to cut fees by year-end
Finance
12:49
CBA: Finance Ministry's note placements don't affect monetary policy
Finance
12:43
Azerbaijan's oil and gas revenues reach nearly 13B manats in nine months
Finance
12:41
Photo
Jeyhun Bayramov: Azerbaijan committed to enhancing OTS effectiveness
Foreign policy